Neutrophil-derived hyperresistinemia in severe acute streptococcal infections

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 4047-4054

  Johansson, Linda ^a   Linnér, Anna ^a   Sundén Cullberg, Jonas ^a   Haggar, Axana ^a   Herwald, Heiko ^b   Loré, Karin ^a   Treutiger, Carl Johan ^a   Norrby Teglund, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; RESISTIN; SUPERANTIGEN; BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ADIPOCYTE; ARTICLE; ASSAY; BLOOD; CELL WALL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERRESISTINEMIA; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; ACUTE DISEASE; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; NECROTIZING FASCIITIS;

ACUTE DISEASE; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CASE-CONTROL STUDIES; FASCIITIS, NECROTIZING; HUMANS; NEUTROPHILS; RESISTIN; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS;

EID: 70349320154     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901541     Document Type: Article

References (36)

1. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310.
2. Philippart, F., and J. M. Cavaillon. 2007. Sepsis mediators. Curr. Infect. Dis. Rep. 9: 358-465.
3. Kellum, J. A., L. Kong, M. P. Fink, L. A. Weissfeld, D. M. Yealy, M. R. Pinsky, J. Fine, A. Krichevsky, R. L. Delude, D. C. Angus, and GenIMS investigators. 2007. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch. Intern. Med. 167: 1655-1663.
4. Yende, S., and D. C. Angus. 2007. Long-term outcomes from sepsis. Curr. Infect. Dis. Rep. 9: 382-386.
5. Sundén-Cullberg, J., T. Nyström, M. I. Lee, G. E. Mullin, L. Tokics, J. Andersson, A. Norrby-Teglund, and C.-J. Treutiger. 2007. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit. Care Med. 35: 1536-1542. (Pubitemid 46809318)
6. Steppan, C. M., S. T. Bailey, S. Bhat, E. J. Brown, R. R. Banerjee, C. M. Wright, H. R. Patel, R. S. Ahima, and M. A. Lazar. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307-312. (Pubitemid 32151228)
7. Banerjee, R. R., S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. E. Wang, M. W. Rajala, A. Pocai, P. E. Schere, et al. 2004. Regulation of fasted blood glucose by resistin. Science 303: 1195-1198.
8. Nagaev, I., M. Bokarewa, A. Tarkowski, and U. Smith. 2006. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One 1: e31.
9. Lehrke, M., M. P. Reilly, S. C. Millington, N. Igbal, D. J. Rader, and M. A. Lazar. 2004. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 1: e45.
10. Boström, E. A., H. F. d'Elia, U. Dahlgren, C. Simark-Mattsson, B. Hasséus, H. Carlsten, A. Tarkowski, and M. Bokarewa. 2008. Salivary resistin reflects local inflammation in Sjögren's syndrome. J. Rheumatol. 35: 2005-2011.
11. Bokarewa, M., I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski. 2005. Resistin, an adipokine with potent inflammatory properties. J. Immunol. 174: 5789-5795. (Pubitemid 40593223)
12. Anderson, P. D., N. N. Mehta, M. L. Wolfe, C. C. Hinkle, L. Pruscino, L. L. Comiskey, J. Tabita-Martinez, K. F. Sellers, M. R. Rickels, R. S. Ahima, and M. P. Reilly. 2007. Innate immunity modulates adipokines in humans. J. Clin. Endocrinol. Metab. 92: 2272-2279.
13. Darenberg, J., N. Ihendyane, J. Sjölin, E. Aufwerber, S. Haidl, P. Follin, J. Andersson, A. Norrby-Teglund, and the StreptIg Study Group. 2003. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: an European randomized double-blind placebo-controlled trial. Clin. Infect. Dis. 37: 333-340.
14. Thulin, P., L. Johansson, D. E. Low, B. S. Gan, M. Kotb, A. McGeer, and A. Norrby-Teglund. 2006. Viable group A streptococci in macrophages during acute soft tissue infections. PLoS Med. 3: 0371-0379.
15. Norrby-Teglund, A., P. Thulin, B. S. Gan, M. Kotb, A. McGeer, J. Andersson, and D. E. Low. 2001. Evidence for superantigen involvement in severe group A streptococcal tissue infection. J. Infect. Dis. 186: 853-860. (Pubitemid 32881089)
16. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression of M type 1 group A streptococci isolates from severe and nonsevere invasive disease. Infect. Immun. 68: 3523-3534. (Pubitemid 30340453)
17. Collin, M., and A. Olsén. 2000. Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol. Microbiol. 36: 1306-1318. (Pubitemid 30449966)
18. Påhlman, L. I., A. I. Olin, J. Darenberg, M. Mörgelin, M. Kotb, H. Herwald, and A. Norrby-Teglund. 2007. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell. Microbiol. 10: 404-414.
19. Kjeldsen, L., H. Sengeløv, K. Lollike, M. H. Nielsen, and N. Borregaard. 1994. Isolation and characterization of gelatinase granules from human neutrophils. Blood 83: 1640-1649.
20. Tapper, H., A. Karlsson, M. Mörgelin, H. Flodgaard, and H. Herwald. 2002. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood 99: 1785-1793.
21. Soehnlein, O., S. Oehmcke, X. Ma, A. G. Rothfuchs, R. Frithiof, N. van Rooijen, M. Mörgelin, H. Herwald, and L. Lindbom. 2008. Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur. Respir. J. 32: 405-412.
22. Savage, D. B., C. P. Sewter, E. S. Klenk, D. G. Segal, A. Vidal-Puig, R. V. Considine, and S. O'Rahilly. 2001. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50: 2199-2202.
23. Patel, L., A. C. Buckels, I. J. Kinghorn, P. R. Murdock, J. D. Holbrook, C. Plumpton, C. H. Macphee, and S. A. Smith. 2003. Resistin is expressed in human macrophages and directly regulated by PPAR γ activators. Biochem. Biophys. Res. Commun. 300: 472-476.
24. Jung, H. S., K. H. Park, Y. M. Cho, S. S. Chung, H. J. Cho, S. Y. Cho, S. J. Kim, S. Y. Kim, H. K. Lee, and K. S. Park. 2006. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc. Res. 69: 76-85.
25. Oren, A., and J. M. Taylor. 1995. The subcellular localization of defensins and myeloperoxidase in human neutrophils: immunocytochemical evidence for azurophilic granule heterogeneity. J. Lab. Clin. Med. 125: 340-347.
26. Herwald, H., H. Cramer, M. Mörgelin, W. Russell, U. Sollenberg, A. Norrby-Teglund, H. Flodgaard, L. Lindblom, and L. Björck. 2004. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116: 367-379.
27. Påhlman, L. I., M. Möreglin, J. Eckert, L. Johansson, W. Russell, K. Riesbeck, O. Soehnlein, L. Lindbom, A. Norrby-Teglund, R. R. Schumann, et al. 2006. Streptococcal M protein: a multipotent and powerful inducer of inflammation. J. Immunol. 177: 1221-1228.
28. Kaser, S., A. Kaser, A. Sandhofer, C. F. Ebenbichler, H. Tilg, and J. R. Patsch. 2003. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309: 286-290.
29. Cohen, G., I. Dalibor, J. Raupachova, and W. H. Hörl. 2008. Resistin inhibits essential functions of polymporphonuclear leukocytes. J. Immunol. 181: 3761-3768.
30. Son, Y. M., S. M. Ahn, M. S. Jang, Y. S. Moon, S. H. Kim, K.-K. Cho, S. H. Han, and C.-H. Yun. 2008. Immunomodulatory effect of resistin in human dendritic cells stimulated with lipoteichoic acid from Staphylococcus aureus. Biochem. Biophys. Res. Com. 376: 599-604.
31. Aruna, B., A. Islam, S. Ghosh, A. K. Singh, M. Vijayalakshmi, F. Ahmad, and N. Z. Ehtesham. 2008. Biophysical analyses of human resistin: oligomer formation suggests novel biological function. Biochemistry 47: 12457-12466.
32. Graveleau, C., V. G. Zaha, A. Mohajer, R. R. Banerjee, N. Dudley-Rucker, C. M. Steppan, M. W. Rajala, P. E. Scherer, R. S. Ahima, M. A. Lazar, and E. D. Abel. 2005. Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for its biological action. J. Biol. Chem. 280: 31679-31685.
33. Patel, S. D., M. W. Rajala, L. Rossetti, P. E. Scherer, and L. Shapiro. 2004. Disulfide-dependent multimeric assembly of resistin family hormones. Science 304: 1154-1158.
34. Verma, S., S. H. Li, C. H. Wang, P. W. Fedak, R. K. Li, R. D. Weisel, and D. A. Mickle. 2003. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108: 736-740.
35. Kawanami, D., K. Maemura, N. Takeda, T. Harada, T. Nojiri, Y. Imai, I. Manabe, K. Utsunomiya, and R. Nagai. 2004. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 314: 415-419.
36. Wanecek, M., E. Weitzberg, A. Rudehill, and A. Oldner. 2000. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 407: 1-15.